XBIO
XENETIC BIOSCIENCES (XBIO) to Acquire Swiss Santersus in Reverse Merger
Xenetic will buy all shares of Santersus AG in a stock-for-stock deal, rename itself Santersus Bio and plans a reverse stock split.
XBIO
Market-moving news on Xenetic Biosciences (NASDAQ: XBIO): filings, earnings, deals and other events, from REDFILED.